On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Moderna has filed complaints in the US and ... and stake a claim to the potentially lucrative opportunity for booster shots targeting new variants like Omicron as COVID-19 becomes endemic.

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

A view of the headquarters of vaccine maker Moderna on May 08, 2020 in Cambridge, Massachusetts. - Image: Maddie Meyer / Staff (Getty Images) Moderna and other vaccine maker stocks plummeted ...

US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...